There was no significant difference in the values of tumor-unrelated measures between the CRC and NT patients, but there was a significant difference in the tumor-node-metastasis (TNM) stage and serum CEA levels between the early and advanced stages of patients. This evidence concerns the gene CEACAM5 and neoplasm.